自然产品在心血管疾病中的作用
Qi Dong1, Gaoying Dai1, Nanhu Quan2
1Department of Cardiovascular Center, The First Hospital of Jilin University, Changchun, 130021, China.
Molecular and cellular biochemistry
|June 16, 2024
概括
老龄化增加了心血管疾病 (CVD) 的风险. 本综述探讨了分子通路,细胞过程和天然产品/饮食习惯,以预防和治疗与年龄相关的心血管疾病.
科学领域:
- 老年学是一门学科.
- 心血管医学 心血管医学
- 分子生物学分子生物学
背景情况:
- 心血管疾病 (CVD) 是全球主要的死亡原因,特别是在老年人群中.
- 与年龄相关的CVD机制包括氧化应激,炎症和心肌重塑.
- 了解这些过程对于开发有效的干预措施至关重要.
研究的目的:
- 审查关键的分子通路和参与与年龄有关的心血管疾病的细胞过程.
- 探索针对这些机制的天然产品和饮食习惯.
- 为减少老年人心血管负担提供见解.
主要方法:
- 关于衰老心血管疾病中的分子途径和细胞过程的文献综述.
- 对自然产品和饮食干预措施对心血管健康的研究进行分析.
- 检查来自动物模型和临床研究的证据.
主要成果:
- 确定了导致与年龄有关的心血管疾病的关键分子和细胞机制.
- 突出自然产品和饮食模式,具有潜在的心血管益处.
- 从临床前和临床研究中综合发现.
结论:
- 自然产品和特定的饮食习惯在治疗与年龄相关的心血管疾病方面表现有前途.
- 进一步的研究可以阐明预防和治疗策略.
- 可以制定建议,以减轻老年人的心血管风险.
更多相关视频
相关概念视频
Cardiovascular Drugs: Classification based on Therapeutic Indications
2.3K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
2.3K
Antianginal Drugs: Nitrates and β-Blockers
571
In cardiovascular health, antianginal drugs combat angina pectoris — a condition marked by chest pain owing to diminished blood flow to the heart.
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
Organic nitrates, such as nitroglycerin, play a pivotal role. Once metabolized, they liberate nitric oxide, a molecular marvel. Nitric oxide triggers guanylyl cyclase and augments cGMP production. This biochemical cascade orchestrates the relaxation of vascular smooth muscles, ushering in vasodilation and enhancing coronary blood flow....
571
Pathophysiology of Cardiac Performance
632
Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
632
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
420
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
420
Heart Failure Drugs: β-Blockers
336
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
336
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
517
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
517


